AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 34626890
Drug: In vivo
RxNorm normalized name: IMAGING AGENTS (IN VIVO) RADIOPHARMACEUTICALS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In vivo exposure therapy (IVET) for 5 weeks
Trial: 93178847
Drug: Interferon alfa
RxNorm normalized name: Interferon alfa
DrugBank: Interferon alfa (DB05258)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alfa therapy
Trial: 33268476
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of NSAIDs
Trial: 35633327
Drug: Protocol treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protocol treatment with a course of hepatoprotector for one month
Trial: 32320639
Drug: Prior history
RxNorm normalized name: Priorix
DrugBank: Rubella virus vaccine (DB10317)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prior history of second-line TB treatment
Trial: 616330511
Drug: 7-valent pneumococcal
RxNorm normalized name: Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-valent pneumococcal conjugate vaccine (7vPCV) in a 1-2-3 month schedule
Trial: 36409491
Drug: Dual pathway
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual pathway inhibition (rivaroxaban 2.5 mg twice daily plus aspirin 100 mg daily)
Trial: 32544914
Drug: Lutein plus
RxNorm normalized name: Lutein Plus with Zeaxanthin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lutein plus DHA group (LT/DHA-G)
Trial: 32265253
Drug: Intravenous thrombolysis
RxNorm normalized name: thrombocytin
DrugBank: Serotonin (DB08839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous thrombolysis (IVT) with recombinant tissue plasminogen activator (rt‐PA)
Trial: 33054890
Drug: Iron and
RxNorm normalized name: beef,iron and wine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron and folic acid (IFA) - 60 mg/d Fe and 400 µg/d folic acid
Trial: 37778226
Drug: Oral anticoagulants
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anticoagulants
Trial: 33077559
Drug: Negative pressure
RxNorm normalized name: DRESSING,NEGATIVE PRESSURE WOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negative pressure wound therapy (NPWT) dressing, n=224
Trial: 33272365
Drug: Atherogenic dyslipidemia
RxNorm normalized name: INVESTIGATIONAL DRUGS FOR DYSLIPIDEMIAS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atherogenic dyslipidemia (triglycerides >150 mg/dl and HDL-C <40 mg/dl in men or <50 mg/dl in women)
Trial: 35611568
Drug: Navigated central
RxNorm normalized name: Rauwolfia alkaloids, centrally acting antiadrenergic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Navigated central retinal laser and 2.0 mg aflibercept
Trial: 34412103
Drug: Aflibercept monotherapy
RxNorm normalized name: Aflibercept
DrugBank: Aflibercept (DB08885)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Aflibercept monotherapy
Trial: 33647718
Drug: GNAstV infection
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GNAstV infection (0.5 mL GNAstV‐JSHA intramuscularly)
Trial: 39171416
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as Usual
Trial: 34787858
Drug: PICC chemotherapy
RxNorm normalized name: STATLOCK PICC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PICC chemotherapy
Trial: 35101832
Drug: Bacillus clausii
RxNorm normalized name: BACILLUS CLAUSII
DrugBank: Bacillus clausii (DB16537)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bacillus clausii UBBC07 (oral suspension of 2 billion spores twice daily for 30 days)
Trial: 39325310
Drug: Both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatment arms
Trial: 34031695
Drug: Convalescent plasma
RxNorm normalized name: Convalescent plasma
DrugBank: COVID-19 convalescent plasma (DB15692)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Convalescent plasma containing neutralizing antibody to SARS-CoV-2
Trial: 32173648
Drug: Combined medication
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined medication of risedronate sodium and raloxifene (SERM)
Trial: 37442883
Drug: Oral Misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral Misoprostol
Trial: 34586927
Drug: Traditional occupational
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional occupational therapy (20 minutes)
Trial: 32101207
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g RS4
Trial: 36247927
Drug: Mazdutide 10
RxNorm normalized name: Mazdutide
DrugBank: Mazdutide (DB19099)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mazdutide 10 mg (2.5 mg weeks 1-4; 5 mg weeks 5-8; 7.5 mg weeks 9-12; 10 mg weeks 13-16)
Trial: 35643873
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D supplementation (20 µg/day)
Trial: 37640861
Drug: Natriuresis-guided therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Natriuresis-guided therapy
Trial: 34872341
Drug: Combination-therapy group
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination-therapy group
Trial: 39616189
Drug: Alteplase treatment
RxNorm normalized name: Alteplase
DrugBank: Alteplase (DB00009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alteplase treatment
Trial: 37823469
Drug: Glucocorticoid treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucocorticoid treatment
Trial: 36309950
Drug: Carbidopa 100
RxNorm normalized name: Carbidopa
DrugBank: Carbidopa (DB00190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbidopa 100 mg with 100 mg IR levodopa without entacapone
Trial: 32907635
Drug: Subcutaneous enoxaparin
RxNorm normalized name: enoxaparin
DrugBank: Enoxaparin (DB01225)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous enoxaparin at the recommended dose of 4,000 IU anti-Xa activity (40 mg/0.4 ml) once daily for 14 days
Trial: 36692418
Drug: Adalimumab 40
RxNorm normalized name: ADALIMUMAB 40MG/0.8ML INJ,PEN,KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adalimumab 40 mg subcutaneously every 2 weeks
Trial: 35057579
Drug: 250 mL
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mL baobab aqueous extract (BAE)
Trial: 35764955
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg AEO BID
Trial: 35764955
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg AEO BID
Trial: 32690536
Drug: Oral suvorexant
RxNorm normalized name: Suvorexant
DrugBank: Suvorexant (DB09034)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral suvorexant (20 mg) once daily starting the night after extubation
Trial: 34861745
Drug: Peri-articular injection
RxNorm normalized name: casanthranol / docusate sodium Oral Capsule [Peri-Colace]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peri-articular injection with saline erector spinae plane block
Trial: 32063238
Drug: Simple reminiscence
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simple reminiscence intervention program (10 weekly sessions lasting 2 hours each)
Trial: 33341707
Drug: Medium dose
RxNorm normalized name: TRIGLYCERIDES,MEDIUM CHAIN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium dose nab-paclitaxel (MD220) 220 mg/m2
Trial: 32989872
Drug: Spironolactone-pioglitazone-metformin (SPIOMET)
RxNorm normalized name: metformin / pioglitazone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone-pioglitazone-metformin (SPIOMET)
Trial: 32926748
Drug: Irsogladine maleate
RxNorm normalized name: maleate
DrugBank: Irsogladine (DB13056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irsogladine maleate (IM) 4 mg/day for 12 weeks
Trial: 39045819
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (Control)
Trial: 33439250
Drug: Nonsurgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonsurgical treatment (closed reduction and cast immobilization)
Trial: 35341362
Drug: Dexamethasone 1
RxNorm normalized name: dexamethasone 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 1 mg/mL
Trial: 35341362
Drug: Dexamethasone 10
RxNorm normalized name: dexamethasone 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 10 mg/mL
Trial: 32987199
Drug: Asfotase alfa
RxNorm normalized name: Asfotase alfa
DrugBank: Asfotase alfa (DB09105)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Asfotase alfa 0.5 mg/kg
Trial: 32987199
Drug: Asfotase alfa
RxNorm normalized name: Asfotase alfa
DrugBank: Asfotase alfa (DB09105)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Asfotase alfa 2.0 mg/kg
Trial: 32987199
Drug: Asfotase alfa
RxNorm normalized name: Asfotase alfa
DrugBank: Asfotase alfa (DB09105)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Asfotase alfa 3.0 mg/kg
Trial: 33822385
Drug: Asfotase alfa
RxNorm normalized name: Asfotase alfa
DrugBank: Asfotase alfa (DB09105)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Asfotase alfa (0.5, 2.0, or 3.0 mg/kg) administered 3 times per week
Trial: 33822385
Drug: Asfotase alfa
RxNorm normalized name: Asfotase alfa
DrugBank: Asfotase alfa (DB09105)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Asfotase alfa (dose-normalized exposure)
Trial: 33822385
Drug: Asfotase alfa
RxNorm normalized name: Asfotase alfa
DrugBank: Asfotase alfa (DB09105)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Asfotase alfa (dose-normalized exposure across BMI categories)
Trial: 33244316
Drug: MVA recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MVA recombinant vaccine expressing HIV-B antigen (MVA-B) via transcutaneous route
Trial: 36526794
Drug: Ibuprofen (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (10 mg/kg)
Trial: 39236052
Drug: Fluoxetine (FLX)
DrugBank: Fluoxetine (DB00472)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluoxetine (FLX)
Trial: 34188144
Drug: Inefficient arsenic
RxNorm normalized name: arsenic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inefficient arsenic metabolism (%iAs) among never-smokers
Trial: 34188144
Drug: Inefficient arsenic
RxNorm normalized name: arsenic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inefficient arsenic metabolism (%MMA) among never-smokers
Trial: 34188144
Drug: Efficient arsenic
RxNorm normalized name: arsenic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Efficient arsenic metabolism (%DMA) among never-smokers
Trial: 34188144
Drug: Inefficient arsenic
RxNorm normalized name: arsenic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inefficient arsenic metabolism (%iAs) among ever-smokers
Trial: 34188144
Drug: Inefficient arsenic
RxNorm normalized name: arsenic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inefficient arsenic metabolism (%MMA) among ever-smokers
Trial: 34188144
Drug: Efficient arsenic
RxNorm normalized name: arsenic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Efficient arsenic metabolism (%DMA) among ever-smokers
Trial: 37697666
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy alone
Trial: 32170589
Drug: Inpatient pharmaceutical
RxNorm normalized name: Impatiens irvingii whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inpatient pharmaceutical care (medication reconciliation, daily pharmacist visits, discharge counseling and education by 2 certified pharmacists)
Trial: 32170589
Drug: Inpatient pharmaceutical
RxNorm normalized name: Impatiens irvingii whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inpatient pharmaceutical care
Trial: 33646060
Drug: PRP-FG dressing
RxNorm normalized name: FG-2216
DrugBank: FG-2216 (DB08687)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRP-FG dressing plus oral vitamin E and C
Trial: 32876328
Drug: Teriparatide 20
RxNorm normalized name: TERIPARATIDE 200UNT/VIL INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teriparatide 20 mcg
Trial: 38247384
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (Control group)
Trial: 35565689
Drug: PFO‐SM (1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PFO‐SM (1% PFO, 180 mL/serving)
Trial: 36320174
Drug: Betahistine 24
RxNorm normalized name: betahistine 24 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betahistine 24 mg every 12 hours for 90 days
Trial: 36320174
Drug: Placebo tablets
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablets every 12 hours for 90 days
Trial: 35587408
Drug: Dialectical Behavior
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dialectical Behavior Therapy for Adolescents (DBT-A)
Trial: 34694249
Drug: US-guided steroid
RxNorm normalized name: Antiinflammatory preparations, non-steroids for topical use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: US-guided steroid injection targeting both subcompartments (APL and EPB)
Trial: 34694249
Drug: US-guided steroid
RxNorm normalized name: Antiinflammatory preparations, non-steroids for topical use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: US-guided steroid injection targeting the EPB subcompartment alone
Trial: 32677876
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose (1 × 10^7 cells)
Trial: 32677876
Drug: Medium dose
RxNorm normalized name: TRIGLYCERIDES,MEDIUM CHAIN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium dose (2 × 10^7 cells)
Trial: 32677876
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose (5 × 10^7 cells)
Trial: 33751917
Drug: Endoscopic injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endoscopic injection of Dextranomer/Hyaluronic Acid (Dx/HA)
Trial: 39738721
Drug: Chemotherapy alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy alone
Trial: 34115851
Drug: ZTL-101 (sublingual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ZTL-101 (sublingual cannabinoid extract)
Trial: 37705972
Drug: Steroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroids
Trial: 616497272
Drug: Intravenous etomidate
RxNorm normalized name: Etomidate
DrugBank: Etomidate (DB00292)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous etomidate alone (group E)
Trial: 37254209
Drug: Monotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy
Trial: 32901255
Drug: Tolvaptan 30
RxNorm normalized name: tolvaptan 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolvaptan 30 mg/day
Trial: 37058788
Drug: Standard treatments
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatments
Trial: 33159976
Drug: ACT-539313 200
RxNorm normalized name: ACT-541468
DrugBank: Daridorexant (DB15031)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ACT-539313 200 mg b.i.d.
Trial: 35656824
Drug: Ticagrelor‐aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticagrelor‐aspirin
Trial: 32475444
Drug: Basal diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basal diet + 200 mg/kg chitosan (CS200)
Trial: 35291272
Drug: Resistant starch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resistant starch 2 (RS2) at doses of 10, 15, and 20 g/d
Trial: 35291272
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of RS2 and sugarcane bagasse at doses of 20, 25, and 30 g/d
Trial: 37315099
Drug: Metacognitive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metacognitive therapy (MCT)
Trial: 35775872
Drug: Dysport +
RxNorm normalized name: Dysport
DrugBank: DaxibotulinumtoxinA (DB17929)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dysport + Profhilo gel
Trial: 32732105
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg dinoprostone vaginally
Trial: 32415472
Drug: Stereotactic body
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stereotactic body radiotherapy (SBRT) with a prescribed dose of 36.25 Gy in 5 fractions, twice a week
Trial: 38206151
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (control)
Trial: 39555827
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment
Trial: 34635989
Drug: Vilaprisan 15
RxNorm normalized name: Vilaprisan
DrugBank: Vilaprisan (DB11971)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vilaprisan 15 mg single dose
Trial: 34635989
Drug: Vilaprisan 1
RxNorm normalized name: Vilaprisan
DrugBank: Vilaprisan (DB11971)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vilaprisan 1 mg/day for 28 days
Trial: 34635989
Drug: Vilaprisan 5
RxNorm normalized name: Vilaprisan
DrugBank: Vilaprisan (DB11971)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vilaprisan 5 mg/day for 28 days
Trial: 35343844
Drug: Medication identification
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication identification device (intervention unit)
Trial: 35343844
Drug: Standard medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard medication administration (control unit)
Trial: 39169298
Drug: Antibiotic prophylaxis
RxNorm normalized name: STONE PROPHYLAXIS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic prophylaxis
Trial: 37414440
Drug: Endoscopic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endoscopic therapy
Trial: 36151961
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of transcervical Foley catheter and sublingual misoprostol
Trial: 36151961
Drug: Sublingual misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual misoprostol alone
Trial: 35871058
Drug: MND-2119 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MND-2119 2 g/day
Trial: 35871058
Drug: MND-2119 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MND-2119 4 g/day
Trial: 33092901
Drug: Physiological saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiological saline solution
Trial: 35093013
Drug: Atogepant 10
RxNorm normalized name: atogepant 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atogepant 10 mg
Trial: 35093013
Drug: Atogepant 60
RxNorm normalized name: atogepant 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atogepant 60 mg
Trial: 34521260
Drug: Atogepant (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atogepant (all doses)
Trial: 39226070
Drug: Semaglutide, 2.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Semaglutide, 2.4 mg
Trial: 35904063
Drug: Topical brimonidine
RxNorm normalized name: brimonidine Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical brimonidine
Trial: 37408018
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (Control)
Trial: 36054562
Drug: Levodopa/carbidopa 400/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levodopa/carbidopa 400/100 mg plus opicapone 50 mg
Trial: 36054562
Drug: Levodopa/carbidopa 500/125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levodopa/carbidopa 500/125 mg without opicapone
Trial: 33518452
Drug: Hyperbaric oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric oxygen therapy (HBOT) at 2 atm absolute for 2 hours × 20 sessions
Trial: 38961397
Drug: Hyperbaric oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric oxygen therapy (HBOT)
Trial: 35106809
Drug: Nebulised unfractionated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulised unfractionated heparin (UFH)
Trial: 38227308
Drug: Placebo (intravenous)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (intravenous)
Trial: 33223425
Drug: RestoreX Penile
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RestoreX Penile Traction Therapy (PTT)
Trial: 34266853
Drug: No surgery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No surgery as part of multimodality treatment
Trial: 36251376
Drug: Nutritional supplement
RxNorm normalized name: Nutritional supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutritional supplement
Trial: 32921367
Drug: Medical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical treatment of nonculprit lesions
Trial: 35294908
Drug: Low concentration/dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low concentration/dose groups (370-0.7, 300-1.0, and 300-0.9)
Trial: 35294908
Drug: Low injection
RxNorm normalized name: Dianeal Low Calcium 1.5 Intraperitoneal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low injection rate groups (2-370 and 2-350)
Trial: 35294908
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard contrast agent protocol)
Trial: 33858011
Drug: Cannabis oil
RxNorm normalized name: Cannabis oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cannabis oil containing 160/40 mg/ml cannabidiol/tetrahydrocannabinol (CBD/THC) for 8 weeks